Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 30, Pages 6876
Publisher
Baishideng Publishing Group Inc.
Online
2016-08-08
DOI
10.3748/wjg.v22.i30.6876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia
- (2016) Samaher Besbes et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
- (2016) Ahmed Kaseb et al. OncoTargets and Therapy
- Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence
- (2016) E-E Ke et al. Therapeutic Advances in Respiratory Disease
- Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer
- (2016) Brian S Bogdanowicz et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response inKRASwild-type metastatic colorectal cancer patients
- (2016) Cristiana Lo Nigro World Journal of Gastrointestinal Oncology
- Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
- (2015) Daniela Cihalova et al. BIOCHEMICAL PHARMACOLOGY
- The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil
- (2015) Marzia B. Gariboldi et al. CANCER LETTERS
- Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives
- (2015) Xu-Qin Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of autophagy inducers in clinical medicine
- (2015) Beth Levine et al. JOURNAL OF CLINICAL INVESTIGATION
- Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1–5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways
- (2015) Gangappa Dharmapuri et al. LEUKEMIA RESEARCH
- Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance
- (2015) Yongchao Zhang et al. Marine Drugs
- Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer
- (2015) Lin Wang et al. PHYTOMEDICINE
- Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity
- (2015) Tao Hu et al. PHYTOMEDICINE
- Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
- (2015) Yingqian Lv et al. OncoTargets and Therapy
- Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
- (2015) Sai-Hong Ou et al. Drug Design Development and Therapy
- In vitro,in vivoandex vivocharacterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1
- (2014) Hui Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
- (2014) Vassiliki Saloura et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cigarette smoking and gastrointestinal diseases: The causal relationship and underlying molecular mechanisms (Review)
- (2014) L.F. LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells
- (2014) Teng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reversal of Mutant KRAS -Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells
- (2014) Koichi Okamoto et al. MOLECULAR CANCER RESEARCH
- Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza
- (2014) Tao Hu et al. PHYTOMEDICINE
- Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
- (2014) Yu-Li Lo et al. PLoS One
- HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
- (2014) Jianfang Chen et al. PLoS One
- Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
- (2014) Ni Xie et al. PLoS One
- Autophagy and human diseases
- (2013) Peidu Jiang et al. CELL RESEARCH
- Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells
- (2013) L. Wang et al. LIFE SCIENCES
- BH3 Mimetics: Status of the Field and New Developments
- (2013) C. Billard MOLECULAR CANCER THERAPEUTICS
- Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
- (2013) A. B. Ward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evading apoptosis in cancer
- (2013) Kaleigh Fernald et al. TRENDS IN CELL BIOLOGY
- Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737
- (2013) A Maamer-Azzabi et al. Cell Death & Disease
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo
- (2012) Yu-Li Lo et al. BIOMEDICINE & PHARMACOTHERAPY
- Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents
- (2012) X. Zhang et al. CELL PROLIFERATION
- Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-Independent Up-Regulation of ABC Proteins
- (2012) Elisa Herraez et al. MOLECULAR PHARMACEUTICS
- Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
- (2012) Ming Ming Zhu et al. PLoS One
- ABCB5 Identifies a Therapy-Refractory Tumor Cell Population in Colorectal Cancer Patients
- (2011) B. J. Wilson et al. CANCER RESEARCH
- Mammalian multidrug-resistance proteins (MRPs)
- (2011) Andrew J. Slot et al. Essays in Biochemistry
- Current standards and new trends in the primary treatment of colorectal cancer
- (2011) Alexander Stein et al. EUROPEAN JOURNAL OF CANCER
- Intracellular trafficking of P-glycoprotein
- (2011) Dong Fu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells
- (2010) Lars Ekblad et al. ANTI-CANCER DRUGS
- Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer
- (2010) Yan Li et al. DRUG METABOLISM REVIEWS
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells
- (2010) Zhenyu Ding et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
- (2010) R. Traini et al. MOLECULAR CANCER THERAPEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
- (2010) Tomohiro Nabekura Toxins
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- Autophagy in Atherosclerosis
- (2009) Wim Martinet et al. CIRCULATION RESEARCH
- Dietary regulation of P-gp function and expression
- (2009) Wenxia Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells
- (2009) Rastislav Jendželovský et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
- (2008) Jianhui Yuan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice
- (2008) Suneet Shukla et al. PHARMACEUTICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now